Neuroimaging

Neuroimaging plays a pivotal role in understanding Alzheimer’s Disease and dementia by providing non-invasive methods to visualize brain structure and function. Techniques like MRI (Magnetic Resonance Imaging) reveal structural changes such as brain atrophy, a hallmark of Alzheimer’s. Functional MRI (fMRI) helps study brain activity patterns, highlighting areas affected by dementia-related cognitive decline. PET (Positron Emission Tomography) scans detect amyloid plaques and tau tangles, key pathological features in Alzheimer’s. These imaging tools aid in early diagnosis, tracking disease progression, and assessing treatment effectiveness. Advances in neuroimaging continue to refine our understanding of how Alzheimer’s alters the brain, offering hope for improved diagnostic accuracy and targeted therapeutic strategies.

Committee Members
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani

Kaoru Sakatani

The University of Tokyo, Japan
Dementia 2023 Speakers
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Suren A Tatulian

Suren A Tatulian

University of Central Florida, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Constantina Mizis

Constantina Mizis

The Latino Alzheimer’s and Memory Disorders Alliance, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Paul Y Song

Paul Y Song

NKGen Biotech, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Marco Ruggiero

Marco Ruggiero

Silver Spring Sagl, Switzerland
Facebook
Watsapp